Pharmaceutical companies continue to invest in several different strategies to increase R&D returns and scientific efficiency. Strategies range from increasing access to research through partnerships or acquisitions, improved execution during clinical trials and patient outreach, and incorporating real world evidence. Despite varied approaches, all strategies have a common thread: access to more data which is generated, stored and analysed in a variety of new and different methods.
However, improvements in scientific efficiency will not be boosted by securing access to a larger set of data alone. Scientists and researchers must be provided with the capability to navigate through increasing amounts of available data to find, understand and prepare relevant data to boost discovery and understanding.
Find out how Informatica is leveraging artificial intelligence to help research professionals increase their efficiency by: